L. Byerly

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia

J. Perentesis, N. Manning, M. Wunderlich, 2021, Frontiers in Oncology.

Metabolic abnormalities in the cancer patient

R. Chlebowski, D. Heber, L. Byerly, 1985, Cancer.

Improved chemotherapy modeling with RAG-based immune deficient mice

J. Perentesis, N. Manning, M. Wunderlich, 2019, PloS one.

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration

Y. Odaka, R. Lang, Yi Zheng, 2017, Proceedings of the National Academy of Sciences.

PDX models of relapsed pediatric AML preserve global gene expression patterns and reveal therapeutic targets

J. Perentesis, N. Manning, Jing Chen, 2022, bioRxiv.